Rudolph Nisi

Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA.

Touchstone Health Partnership, Inc. provides care management services. The firm operates as a Provider Sponsored Organization and offers an alternative to traditional fee-for-service (“FFS”) Medicare and its zero and low dollar premium plans with benefits that include, but are not limited to, medical, pharmacy, dental, vision, hearing and mental health. The company was founded by Timothy J. O'Donnell and James Hickey in 1998 and is headquartered in New York, NY.

ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.

Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA.

Tempra Technology, Inc. is a research and development applications company based in an undisclosed location. The private company is based in Bradenton, FL. Tempra Technology has developed and patented both self-cooling and self-heating technologies, making them a leader in the development of instant, self-heating and self-chilling product technology. The company has developed innovative products for food & beverage, medical, therapy, sports medicine, equestrian and consumer product markets. Tempra Technology was the first company to develop a completely functional, 100% safe, environmentally friendly self-chilling beverage can. The company has also developed self-heating technologies for hand-held foods such as soups, beverages, pasta dishes, and sauces. Additionally, Tempra Technology offers instant self-heating and self-chilling gel packs and a variety of thermal wraps. All of their products are designed to provide instant, portable, safe, long-lasting thermal technology anytime, anywhere. The company was founded in 1992 by Barney J. Guarino, who has been the CEO since then.

New York Westchester Square Medical Center engages in the provision of medical services that talks about steroids, bodybuilding, fitness, and health. The company was founded on August 2, 2000 and is headquartered in Bronx, NY.

Part of VNS Choice, New York-Presbyterian Health System Select LLC is a hospital operator. The company is based in New York, NY.